Florian Gantner
Papers
1
Total Citations
66
H-Index
1
About
Florian Gantner is a leading figure in respiratory drug discovery, whose work centers on developing advanced in vitro models of the human airway. His primary research focus is the miniaturization and optimization of epithelial cell culture systems, enabling high-throughput screening for pulmonary therapeutics. Gantner's most notable contribution is the development of a miniaturized 96-Transwell air-liquid interface (ALI) human small airway epithelial model, published in 2020 and cited over 66 times. This groundbreaking platform overcomes a critical bottleneck in respiratory research: the limited number of primary airway cells obtainable from clinical samples and their poor capacity to divide ex vivo. By creating a robust, scalable 96-well microplate system, Gantner has empowered researchers to conduct more physiologically relevant drug efficacy and toxicity assays with far fewer cells. His work has significantly accelerated the pace of preclinical testing for conditions like asthma, COPD, and cystic fibrosis, bridging the gap between basic cell biology and translational pharmaceutical development. Through this innovation, Gantner has established himself as a key enabler of next-generation respiratory medicine.
Research Focus
Key Achievements
Top Papers
- 1